New syndrome connects heart disease, metabolic disorders, and kidney disease

  • 2 Min To Read
  • 6 months ago

The American Heart Association (AHA) has released a new advisory on a condition known as cardiovascular-kidney-metabolic (CKM) syndrome. This syndrome refers to the connection between heart disease, kidney disease, and metabolic disorders such as diabetes. The AHA advisory includes updated approaches to screening, stages, and treatment for CKM.

Heart disease has long been associated with other chronic conditions, and it is the leading cause of death in the United States. According to the AHA, one in three adults has multiple risk factors for heart disease, metabolic disorders, and kidney disease. The AHA's advisory aims to redefine the risk, prevention, and management of cardiovascular disease by addressing these interconnected conditions.

Health experts have previously recognized the links between cardiovascular disease, obesity, type 2 diabetes, and chronic kidney disease. The AHA's advisory, published in the journal Circulation, emphasizes the importance of early identification and screening for CKM syndrome. By identifying kidney and metabolic disease early on, healthcare providers can implement protective therapies to prevent heart disease and effectively manage existing heart disease.

The advisory outlines the four stages of CKM syndrome, ranging from no risk factors to multiple risk factors. Additionally, it encourages healthcare providers to consider societal factors that may contribute to increased risk, such as economic stability, access to healthcare, and education level. The AHA recommends collaboration between physicians from different specialties to ensure comprehensive care for patients with CKM.

The advisory also highlights the need for a more proactive approach to healthcare, focusing on individual risk factors and early intervention. By considering social determinants of health, such as poverty and lack of access to education, physicians can provide more effective care to patients. The AHA hopes that this advisory will lead to improved treatment options and better outcomes for individuals with CKM.

To assess risk and develop personalized treatment plans, healthcare providers may consider factors such as weight, body mass index, blood pressure, cholesterol levels, and blood sugar levels. By quantifying risk factors, physicians can develop targeted strategies to reduce the risk of heart attack, stroke, and diabetes.

Overall, the AHA's advisory on CKM syndrome aims to promote collaboration among healthcare providers, redefine disease management, and consider social determinants of health. By addressing these interconnected conditions and implementing early screening and treatment, the AHA hopes to improve outcomes for individuals with CKM.


More from Press Rundown